Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary
Content archived on 2024-05-24

Surveillance of vaccine preventable hepatitis (HEPNET)

Objective

Hepatitis B has been documented to be a serious threat to the health of populations in the region, with low to intermediate infelicity in the EU countries and intermediate to high infelicity in the Associated States (AS) (despite the availability of safe and effective vaccines since more than 18 years). Furthermore, many AS are in a transition epidemiological situation for hepatitis A, with difficult decisions on implementation of hepatitis A immunization programmes. The overall aim of HEPNET is to take stock, co-ordinate, strengthen and standardise the country-specific surveillance and prevention activity of viral hepatitis A and B This will be achieved by establishing a feasibility study of a future network on surveillance of hepatitis A and B in the 28 participating counties, integrating the expert epidemiology and public health groups involved in the surveillance of infectious diseases in the respective countries The project involves the establishment of comparable methodologies by the standardisation of case definitions, surveillance methods, and laboratory confirmation and capitalize on the successes in countries, shared experience and lessons learnt from other countries.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.

You need to log in or register to use this function

Call for proposal

Data not available

Coordinator

UNIVERSITAIRE INSTELLING ANTWERPEN - UNIVERSITEIT ANTWERPEN
EU contribution
No data
Address
Universiteitsplein 1
2610 WILRIJK (ANTWERPEN)
Belgium

See on map

Total cost
No data

Participants (6)